wow...you must be smart ! do you sit in a little room with a bunch of donkeys posting all day & swinging trades for 10c ??? you be da playa
It should sell at a discount to DAL for now---as AAL still has potential risk coming out of bankruptcy, consolidation issues. DAL has been shareholder friendly over the past couple of years --which has won them friends & a higher valuation. Also, many institutions do not have AAL on their approved list for purchase as its post-bankrupt & takes time. Look for AAL to pick up new vanilla buyers as AAL eventually gets into S&P500 & gets index buying (DAL already there). As the AAL story continues to mature (now buybacks, dividends---following DAL's example) the stock will rise any way. A strong sector lifts all boats (planes !) so BOTH will participate on the upside. Don't fool around looking at P/Es as they are skewed to taxes----cash flow & PRASMs are better indicators. Analyst estimates are all over the map depending on their bias but there's a lot of room UP for AAL & slightly less for DAL --- but both will work nicely over the next year.
Hey clown---did you miss the obvious ??? Board members sold MILLIONS of shares at virtually DOUBLE the price this past week. Is that too COMPLICATED for you ? are you aware of it ? get in the game blockhead. THLD went down over 50% after these sales despite all of the cheerleading going on by beachball et al noting how THLD-302 was the Holy Grail.
Maybe you are clueless----there was no law that said the insiders had to exercise & sell--but they did. You are the fool---the stock went down 50% in a short period of time & all of the retail buyers looking foe winning lottery tickets bought in----with poor results. Are you aware of what's going on ???? do you have A CLUE where the stock is ??? Please PLEASE go away you fool.
Hey bonehead---what roc did you crawl out from ? THLD is a spec play with no products & no sales ---are you just waking up ???
are your feeling still hurt over the Dendreon bankruptcy ? maybe someday yo can have a winner ! you have been an absolute font of misinformation poor little putz
oh sure --- so you got smacked & watched a 50% DROP in a matter of weeks. keep your eye on the ball----sounds like you better be doing some homework on this one.
Nice call on Dendreon little rookie ! as usual you think you have all the answers---guess you didn't see BANKRUPTCY for DNDN did you.
Some thought the insiders dumping millions of shares over the last year were stupid and short-sighted. It appears that they had a better view of what was going on inside the building & voted with their shares. With a CEO who has never demonstrated the ability to bring a product to market over a dozen years at the helm apparently has inspired no confidence in either insiders or professional investors who have shunned the stock.
Sadly the little retail guy has been left holding the beachball.
More importantly -- what has the ceo & his management team brought to the table for shareholders over the last DOZEN+ YEARS ???? does anyone have that answer ? does everybody get a free ride for that long in every job ??? DOZEN+ YEARS ???
Its simple weed. Some idiot has ben promoting this little spec for about 2 years now & has not been able to get one thing right. It's always comical when you have a little putz retail holder not really sure what the numbers are on the lottery ticket & why they never are right. Dendreon--DNDN----now THAT was a good one ! Let's not forget that Celgene--CELG---was garbage ! Little putz retail advice ! Keep the losers avoid the winners ! Too smart for your own good !!! HAAAAA ! Keep the little beachball comments coming ! Maybe THLD gets orphan drug status too !!! HAAAA !!! BIGGEST BIOTECH BULL MARKET & little rookie can't get outa the way !! You funnneeeeee !
I am not short. "institutions" hold stock primarily as part of index funds (Russell 2000) & it's not much money anyway. I can't see any active biotech managers of any note that has made any substantial commitment to the management or the stock. I will say that there are hedge funds who employ long/short strategies in this sector who go long names like REGN & ALXN and short a basket of spec names with no products that are short names like THLD.
As far at their 10Q its all boilerplate---standard commentary. No surprise there. The only surprise has been timelines that continue to be pushed out. What valuation do you give to potential sales in 2020 ???